Dr Soliman Abdel Kader Fakeeh (4017)

Saudi Arabia
Currency in SAR
44.95
-0.15(-0.33%)
Delayed Data·
4017 Scorecard
Full Analysis
Prominent player in the Healthcare Providers & Services industry
Earnings results expected in 15 days
Fair Value
Day's Range
44.8045.15
52 wk Range
43.2072.90
Key Statistics
Edit
Bid/Ask
44.95 / 45.00
Prev. Close
45.1
Open
45.1
Day's Range
44.8-45.15
52 wk Range
43.2-72.9
Volume
134.3K
Average Volume (3m)
533.24K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4017 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
60.22
Upside
+33.97%
Members' Sentiments
Bearish
Bullish
ProTips
Trading near 52-week low
No news in this category
Looks like there are no results in this news category

Dr Soliman Abdel Kader Fakeeh Company Profile

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. It also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, the company engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.

Compare 4017 to Peers and Sector

Metrics to compare
4017
Peers
Sector
Relationship
P/E Ratio
36.0x23.4x−0.5x
PEG Ratio
−6.810.460.00
Price/Book
3.5x3.6x2.6x
Price / LTM Sales
3.7x4.3x2.9x
Upside (Analyst Target)
35.3%22.6%53.0%
Fair Value Upside
Unlock13.6%8.9%Unlock

Analyst Ratings

1 Buy
4 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 60.22
(+33.97% Upside)

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
0.43 / 0.43
Revenue / Forecast
743.00M / 770.00M
EPS Revisions
Last 90 days

FAQ

What Is the Dr Soliman Abdel Kader Fakeeh (4017) Stock Price Today?

The Dr Soliman Abdel Kader Fakeeh stock price today is 44.95

What Stock Exchange Does Dr Soliman Abdel Kader Fakeeh Trade On?

Dr Soliman Abdel Kader Fakeeh is listed and trades on the Saudi Arabia Stock Exchange stock exchange.

What Is the Stock Symbol for Dr Soliman Abdel Kader Fakeeh?

The stock symbol for Dr Soliman Abdel Kader Fakeeh is "4017."

What Is the Dr Soliman Abdel Kader Fakeeh Market Cap?

As of today, Dr Soliman Abdel Kader Fakeeh market cap is 10.37B.

What Is Dr Soliman Abdel Kader Fakeeh's Earnings Per Share (TTM)?

The Dr Soliman Abdel Kader Fakeeh EPS (TTM) is 1.32.

When Is the Next Dr Soliman Abdel Kader Fakeeh Earnings Date?

Dr Soliman Abdel Kader Fakeeh will release its next earnings report on 27 May 2025.

From a Technical Analysis Perspective, Is 4017 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.